2024 annual financial data
ADC Therapeutics 2024 Net margin
Direct answer
Net margin was -222.83%.
Operating income was -130,654,000 USD and net income was -157,846,000 USD.
Operating cash flow was -123,835,000 USD.
Get free ADC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 70,837,000 USD
- Operating income
- -130,654,000 USD
- Net income
- -157,846,000 USD
- Operating cash flow
- -123,835,000 USD